Detalles de la búsqueda
1.
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
Int J Gynecol Cancer
; 33(8): 1208-1214, 2023 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37380217
2.
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma.
Gynecol Oncol
; 167(2): 226-233, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055813
3.
Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221.
Clin Cancer Res
; 25(20): 6052-6060, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31308062
4.
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium.
Clin Cancer Res
; 24(24): 6168-6174, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30108107
Resultados
1 -
4
de 4
1
Próxima >
>>